伊沙佐米、来那度胺、地塞米松治疗复发/难治多发性骨髓瘤的疗效与安全性分析：一项国内多中心真实世界研究

OBJECTIVE: To evaluate the efficacy and safety profile of ixazomib/lenalidomide/dexamethasone (IRd) in Chinese patients with relapsed/refractory multiple myeloma (MM). METHODS: This study comprising 14 medical centers in China included patients with relapsed/refractory MM who received at least. Ixaz...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2021
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501289/
https://www.ncbi.nlm.nih.gov/pubmed/34547867
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.08.003

Ejemplares similares

Ejemplares similares